Peri-Operative Magnesium Infusion to Prevent Atrial Fibrillation Evaluated.

Clinical trial NCT05669417 · TERMINATED

Trial details

NCT number: NCT05669417
Sponsor: HagaZiekenhuis
Status: TERMINATED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Atrial Fibrillation New Onset

Start date: 2022-08-01
Primary completion: 2023-07-17
Enrollment: 265

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.